The Role Of Genetic Factors In The Pathogenesis Of Urolithiasis Development
Azimova S. B. , Tashkent State Medical University, Tashkent, Uzbekistan Urdasheva L. Sh. , Tashkent State Medical University, Tashkent, Uzbekistan Sharipova P. A. , Tashkent State Medical University, Tashkent, UzbekistanAbstract
This study assesses the prognostic significance of polymorphisms in the uromodulin (UMOD) and vitamin D receptor (VDR) genes in the pathogenesis of urolithiasis (ICD) in the Uzbek population. Genotyping of UMOD rs429639 and VDR BsmI (c.IVS7 G>A) single nucleotide polymorphisms was performed by polymerase chain reaction (PCR) with allele-specific primers in 82 patients with urolithiasis and a control group. Results showed that the T allele and TT genotype of UMOD rs429639 (OR = 1.85, 95% CI: 1.05–3.29, p = 0.0337) and the G allele and GG genotype of VDR BsmI (OR = 2.18, 95% CI: 1.05–4.55, p = 0.0347) are significantly associated with increased risk of urolithiasis. Conversely, the C allele/CT genotype of UMOD and the A allele/GA genotype of VDR demonstrate protective effects. The UMOD locus deviated significantly from Hardy–Weinberg equilibrium in both groups, while the VDR locus was in equilibrium. These findings confirm the role of uromodulin and vitamin D receptor in sodium reabsorption, calcium-phosphorus homeostasis, and lithogenesis, and may be useful for developing genetic risk panels for urolithiasis in the Uzbek population.
Keywords
Urolithiasis, nephrolithiasis, genetic polymorphism
References
Devuyst O., Olinger E., Rampoldi L. Uromodulin biology: from gene to kidney disease. // Kidney International. – 2017. – Vol. 91, № 6. – С. 1270–1281.
Trinchieri A. Epidemiology of urolithiasis. // Urologia Internationalis. – 2019. – Vol. 103, № 3. – С. 125–133.
Köttgen A., Pattaro C., Böger C. A., et al. Uromodulin levels and genetic variants associated with kidney function and disease. // Nature Genetics. – 2010. – Vol. 42, № 5. – С. 369–375.
Serdar M., Aydin H., Akbaş A., et al. Association between UMOD polymorphisms and nephrolithiasis: population-based evidence. // Clinical Genetics. – 2018. – Vol. 94, № 4. – С. 397–404.
Ağladıoğlu S., Dalgıç N., Tanrıverdi M. H., et al. Vitamin D receptor gene polymorphisms and calcium metabolism: implications for urolithiasis. // Journal of Endocrinology and Metabolism. – 2016. – Vol. 6, № 5. – С. 145–151.
Fang Y., Zhang Y., Wang L., et al. VDR gene variants and risk of kidney stone disease: a meta-analysis across populations. // BMC Medical Genetics. – 2019. – Vol. 20, № 1. – С. 1–12.
Shakhssalim N., Basiri A., Moghaddam S., et al. Genetic and biochemical determinants of calcium stone formation. // Urology Journal. – 2018. – Vol. 15, № 3. – С. 125–131.
Azimova S.B., Samieva G. U., Xidirova S.X. Pathogenetic Basis for the Development of Lactase Enzyme Deficiency// American Journal of Medicine and Medical Sciences 2024, p 466-470.
Urdasheva L.SH., Azimiva S.B., Khalikov H.D. Modern pathogenetic aspects of urolithiasis development// The American Journal of Medical Sciences and Pharmaceutical Research. 2025, p 21-24.
Закирходжаев Ш.Я., Азимова С.Б. Диагностическая значимость клинико-биохимических и генетических маркеров при хроническом гепатите С// Теоретическая и клиническая медицина, 2018, №1, с.99-101
Azimova S.B., Talipova N.K., Nurmukhamedova N.S. Principal aspects of pathogenesis of chronic viral hepatitis in Uzbekistan// Central Asian Journal of Medicine, 2020, #3, p. 148-157.
Wang S, Wang X, Wu J. Association of vitamin D receptor gene polymorphism and calcium urolithiasis in the Chinese Han population. // Urol Res. 2012. Vol. 40, N 4. P. 277-284.
Lin Y, Mao Q, Zheng X. Vitamin D receptor genetic polymorphisms and the risk of urolithiasis: a meta-analysis. // Urol internat. 2011. Vol.86. P. 249-255.
Attanasio M. The genetic components of idiopathic nephrolithiasis. // Pediat Nephrol. 2011. Vol. 26, N 3. P.337346.
Download and View Statistics
Copyright License
Copyright (c) 2026 Azimova S. B., Urdasheva L. Sh., Sharipova P. A.

This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors retain the copyright of their manuscripts, and all Open Access articles are disseminated under the terms of the Creative Commons Attribution License 4.0 (CC-BY), which licenses unrestricted use, distribution, and reproduction in any medium, provided that the original work is appropriately cited. The use of general descriptive names, trade names, trademarks, and so forth in this publication, even if not specifically identified, does not imply that these names are not protected by the relevant laws and regulations.


Medical Science
| Open Access |
DOI: